Epi Auto Injector denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for epi auto injector are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Your Epinephrine Auto-Injector: Prior Authorization Required

Epinephrine auto-injectors are life-saving emergency medications used to treat anaphylaxis. Despite their critical nature, BCBS and many insurers require prior authorization (PA) before they will cover these devices. A PA denial does not mean the device is not medically necessary — it means the administrative step of obtaining advance approval was either not completed or was completed but not approved. This is one of the most common and most successfully appealed denial types.

## Why This Denial Is Appealable

Prior authorization denials are procedural in nature. The appeal process allows you to submit clinical evidence demonstrating that the device meets all of the plan's coverage criteria. Courts and regulators have increasingly scrutinized PA denials for emergency medications, and a well-documented appeal has a strong track record of success at the internal or external review level.

## Your Federal Appeal Rights

• Internal appeal: Under ACA Section 2719 and ERISA Section 503, you are entitled to a full internal review. Your denial letter will specify the deadline — typically 180 days from the denial date for non-grandfathered plans.
• External review: If the internal appeal is upheld, escalate to an Independent Review Organization (IRO). File within approximately four months of exhausting internal remedies.
• Expedited review: Because anaphylaxis is life-threatening, you should simultaneously request expedited processing at every level. Expedited decisions are generally required within 72 hours of a complete submission.

## Documentation to Gather

• Diagnosis confirmation: Records from your allergist, immunologist, or treating physician documenting the underlying condition (e.g., food allergy, venom allergy, idiopathic anaphylaxis) that creates anaphylaxis risk.
• Prior reaction history: ER visit records, urgent care notes, or physician documentation of previous anaphylactic or severe allergic episodes.
• Prescriber medical-necessity letter: A letter from your prescriber explaining your diagnosis, the severity of your anaphylaxis risk, and why continuous access to an epinephrine auto-injector is necessary.
• Clinical guidelines reference: Your prescriber can cite the applicable guideline organization (such as relevant allergy/immunology society guidance) supporting epinephrine auto-injectors as first-line emergency treatment.

## Criteria-Mapping Structure

Obtain BCBS's prior authorization criteria for epinephrine auto-injectors from their published medical or coverage policy. Map each requirement to your documentation:

| PA Requirement | Supporting Evidence | |---|---| | Qualifying diagnosis or documented anaphylaxis risk | Allergist/ER records with diagnosis codes and dates | | Prescriber specialty or confirmation | Prescribing physician credentials and specialty notation | | Failure or contraindication of alternatives (if required) | Prescriber letter addressing any step-therapy requirements | | Medical necessity narrative | Detailed prescriber letter |

Verify the exact current PA criteria against BCBS's published coverage policy before submitting — policies are updated periodically and your appeal must address the current version.